The Future of Biopharma Partnering, S&E | Dr. Smbat Rafayelyan, Founder & CEO of Bioneex

In this episode of the Bioneex Podcast, Dr. Smbat Rafayelyan, Founder & CEO of Bioneex, discusses the future of biopharma partnering, Search & Evaluation, and the role of AI in biotech and pharma dealmaking. He shares his journey from Pfizer and Sanofi to founding Bioneex, an AI-powered platform helping drug development companies, biopharma partners, and investors connect around therapeutic assets more efficiently. The conversation explores how Bioneex increases asset visibility for biotech companies while helping business development, Search & Evaluation, and investment teams identify and assess opportunities faster. Dr. Rafayelyan also discusses AI-powered asset search, due diligence, de-risking, and Bioneex’s partnership with GATC Health, including the integration of Derisq™ for predictive asset evaluation. The episode also covers startup leadership, building a digital life sciences company, managing talent, and Bioneex’s next milestones in the evolving biopharma partnering landscape.